TL;DR
Researchers have created the first comprehensive, spatially-resolved proteome atlas of the human brain, revealing that protein diversity is much higher than previously thought and that brain regions specialize through post-transcriptional mechanisms. This atlas provides a crucial resource for understanding brain function and disease, as demonstrated by its application in identifying novel drug targets for epilepsy.
What Problem Does This Paper Address?
The human brain is incredibly complex, with different regions performing specialized functions. However, understanding how this specialization is achieved at the molecular level, particularly at the protein level, has been a significant challenge. While transcriptomic atlases have mapped gene expression, they show surprisingly little variation across cortical regions. This suggests that other layers of regulation, like post-transcriptional modifications, play a critical role in brain function and specialization. Furthermore, identifying therapeutic targets for neurological disorders, especially those affecting the cortex like epilepsy, has been difficult, partly because proteins are the primary drug targets, and their abundance doesn't always correlate with gene expression. This paper aims to bridge this gap by creating a detailed proteomic map of the brain and using it to uncover molecular principles of brain organization and identify potential therapeutic targets.
Methods
The study employed a multi-omics approach, integrating proteomics with transcriptomics and neuroimaging. Key techniques included:
- Pressure Cycling Technology (PCT): Used for efficient protein extraction from small tissue samples, crucial for preserving protein integrity.
- Data-Independent Acquisition Mass Spectrometry (DIA-MS): A high-throughput method for comprehensive proteome profiling.
- Magnetic Resonance Imaging (MRI): Used to guide sample collection and map tissue locations to standardized anatomical coordinates (MNI space), enabling precise spatial registration.
- Brainnetome Atlas: Used to assign cortical regions to functional network memberships based on connectivity and activation patterns.
- FAXP (Filter-Aided Expansion Proteomics): A technique used to expand tissue samples, allowing for more precise microdissection of specific anatomical regions, particularly useful for cross-species comparisons.
- Unsupervised Multi-Omics Clustering (MOVICS framework): Applied to identify distinct molecular territories (MBTs) that transcend traditional anatomical boundaries.
- Weighted Correlation Network Analysis (WGCNA): Used to identify co-expression modules in epilepsy patient samples and compare them to healthy controls.
Datasets
- Human Brain Tissue: Samples from four neurologically healthy individuals (two male, two female) were used to generate the core proteome atlas.
- Epilepsy Patient Tissue: 90 brain tissue samples from 49 individuals with epilepsy were analyzed to demonstrate the atlas's translational value.
- Allen Brain Atlas Microarray Data: Publicly available transcriptomic data from six neurotypical donors was used for comparison with proteomic data.
- Brainnetome Atlas: Used for functional network membership assignment.
- Paxinos and Watson Human Brain Atlas: Used for anatomical annotation of subcortical regions.
- ChEMBL and DrugBank Databases: Used for identifying potential drug targets.
- Mouse Brain Tissue: Samples from nine mice were used for cross-species proteomic analysis using FAXP.
Key Insights and Ideas
- Protein Diversity Drives Cortical Specialization: The study reveals that cortical regions, despite having similar transcriptomes, exhibit significantly higher protein diversity. This suggests that post-transcriptional regulation is a primary driver of functional specialization in the cortex.
- Molecular Territories Transcend Anatomy: Unsupervised clustering identified 21 "Molecular Brain Territories" (MBTs) that don't strictly adhere to anatomical boundaries but instead reflect underlying metabolic demands and functional specialization patterns.
- Metabolic Investment Balances Functional Demands: Brain regions appear to balance their metabolic investment with their functional demands. Regions involved in complex cognitive functions maintain metabolically expensive machinery, making them vulnerable to neurodegeneration, while specialized sensory regions achieve efficiency through streamlined molecular architectures.
- Sex-Specific and Hemispheric Differences: The atlas revealed distinct proteomic signatures related to sex and hemisphere, suggesting underlying molecular mechanisms for differential disease susceptibility and functional lateralization.
- Epilepsy Disrupts Astrocyte Metabolism and Proteostasis: Application to epilepsy samples uncovered disrupted astrocyte metabolism and protein homeostasis, highlighting novel therapeutic avenues.
Key Results
- Comprehensive Proteome Atlas: The study generated a spatially-resolved proteome atlas of the human brain, quantifying 11,772 proteins across 2367 MRI-guided sample sites from four individuals.
- Protein vs. Transcript Diversity: Cortical regions showed approximately 1.6 times higher protein diversity than transcript diversity.
- Molecular Brain Territories (MBTs): 21 distinct MBTs were identified, revealing novel organizational principles of the brain.
- Epilepsy Drug Targets: The atlas facilitated the identification of 51 novel drug targets for epilepsy, including the purinergic receptor P2RX7, which is already being investigated for therapeutic repurposing.
- Cross-Species Conservation: Post-transcriptional regulation of synaptic proteins was found to be evolutionarily conserved between humans and mice, though regional implementation differed.
Limitations and Future Work
- Cohort Size: The study acknowledges that the cohort size, while providing unprecedented spatial coverage, cannot capture population-level variation. Future expansions should incorporate larger, diverse cohorts.
- Integration with Single-Cell Resolution: The authors suggest that future expansions should integrate with single-cell resolution to dissect cell-type contributions to regional signatures.
- Emerging Technologies: The resource will be made available to researchers, enabling integration with emerging technologies like spatial transcriptomics, single-cell proteomics, and functional imaging to further enhance resolution and utility.
- Therapeutic Development: The atlas provides a framework for identifying and validating therapeutic targets, moving beyond symptomatic treatment towards targeting disease-driving molecular networks.
Summary updated